Latest France News

Electro Optic Systems has completed its acquisition of the UK-based Interceptor business, marking a strategic expansion into the AUKUS market and enhancing its counter-drone technology portfolio.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

National Australia Bank updates its dividend details, confirming a fully franked payout of AUD 0.85 per share for the half-year ending September 2025, with flexible currency payment options for shareholders.

Orezone Gold Corporation reports solid Q3-2025 results from its Bomboré Gold Mine, progressing its Stage 1 hard rock expansion on schedule while revising cost guidance higher due to external pressures.

Orezone Gold Corporation reported solid Q3 and nine-month 2025 results from its Bomboré gold mine, with production slightly down but revenue boosted by higher gold prices. The company’s hard rock expansion is on track for first gold in December 2025, supporting its 2025 production guidance.

Orezone Gold Corporation reported solid revenue growth and net earnings for Q3 2025, underpinned by progress at its Bomboré gold mine and strategic financing moves. The company also navigated a key ownership change with the Burkina Faso government increasing its stake.

National Australia Bank has announced a fully franked ordinary dividend of AUD 0.85 per share for the half-year ending September 2025, offering shareholders multiple currency payment options and participation in dividend reinvestment and bonus security plans.

CSL Limited’s latest Capital Markets Day presentation highlights CSL Seqirus’s strategic positioning to capitalize on a recovering US influenza vaccine market and global growth opportunities.

Immutep Limited has received a significant A$4.6 million cash payment from the French government’s R&D tax incentive scheme, supporting its ongoing immunotherapy clinical programs.

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

Cobalt Blue Holdings advances its Kwinana Cobalt Refinery with a critical Works Approval and secures letters of intent covering 70% of initial production, while its Broken Hill Cobalt Project gains a three-year Major Project Status extension.